Phramalive.com - EXTON, Pa., November 07, 2006 /PRNewswire/ — Morphotek(R) Inc., a privately held biopharmaceutical company focused on the discovery and development of therapeutic monoclonal antibodies, announces that the United States Food and Drug Administration …